Search SBC
SBC Medical Group Holdings Inc
Nasdaq, Nasdaq · CIK 1930313
Last close5.09
Daily change+0.02 (0.39%)
10 Years gain-48.90%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
SBC · STANDARD
SIC 8011 · Services-Offices & Clinics of Doctors of Medicine · Fiscal year end 1231
Fundamental
52.9Momentum
60.6Acceleration
60.6Confidence
66.0Annual Revenue3
Quarterly Revenue10
Annual CFO4
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth2.5 / 25
Quality12.8 / 25
Capital Efficiency20.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Operating leverageOperating margin improved by 2.1156 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 0.6775%.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Warnings
Inventory anomaly · MEDIUMInventory growth is materially above revenue growth.
Gross margin compression · MEDIUMGross margin compressed by 7.0011 percentage points.
Key Metrics
Revenue Growth TTM-9.59%OK
Revenue CAGR 3Yn/aINSUFFICIENT_HISTORY
Gross Margin70.94%OK
Operating Margin37.5%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC39.98%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-0.68%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $173.61M | $127.28M | $67.49M | $24.67M | $23.27M | 73.32% | 38.87% | 13.4% | 43.07% | 103M |
| 2025 FY Dec 31, 2024 | $205.42M | $156.05M | $70.30M | $20.58M | $18.02M | 75.97% | 34.23% | 8.77% | 78.7% | 96.56M |
| 2024 FY Dec 31, 2023 | $193.54M | $137.30M | $70.66M | $50.67M | $42.13M | 70.94% | 36.51% | 21.77% | 257.88% | 94.19M |
| 2023 FY Dec 31, 2022 | n/a | -$161,644.00 | -$543,695.00 | -$462,816.00 | n/a | n/a | n/a | n/a | n/a | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $178.96M | sum latest 4 fiscal quarters Revenue | OK | 0001193125-26-347843, 0001193125-25-281466 |
| Revenue Growth TTM | -9.59% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001193125-26-347843, 0001193125-25-281466 |
| Revenue CAGR 3Y | n/a | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001193125-26-127557 |
| Revenue CAGR 5Y | n/a | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | INSUFFICIENT_HISTORY | 0001193125-26-127557 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001193125-26-127557 |
| Operating Income Growth | -4.18% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001193125-26-347843, 0001193125-25-281466 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 70.94% | Gross Profit / Revenue | OK | 0001193125-26-347843, 0001193125-25-281466 |
| Operating Margin | 37.5% | Operating Income / Revenue | OK | 0001193125-26-347843, 0001193125-25-281466 |
| ROIC | 39.98% | NOPAT / Average Invested Capital | OK | 0001193125-26-347843, 0001193125-25-281466 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001193125-26-347843 |
| Interest Coverage | 203.69x | Operating Income / abs(Interest Expense) | OK | derived |
| Current Ratio | 3.31x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 4.89x | (Cash + Short-term Investments) / Total Debt | OK | 0001193125-26-347843 |